AIM Biotech is a leading bioengineering company, offering scalable, cost-effective 3D cell culture platforms, drug screening services, and customized assay development. By combining model realism and platform simplicity, AIM’s plug-and-play technologies empower drug developers to mimic human biology with precision, delivering clinically-relevant data.

Alcyomics is a pre-clinical service provider using Skimune®, non-artificial human skin explants to predict adverse immune reactions of novel compounds. The Skimune® platform also assess the efficacy of monoclonal antibodies, immune inhibitors and safety of cellular therapies.

Altis Biosystems has developed a stem cell platform that recreates the human intestinal epithelium, using proliferative stem cells and terminally differentiated cells. These cells are sourced from transplant-grade intestine. It is a high-throughput format, ideal for drug screening.

AlveoliX has developed an adaptable organ-on-chip platform that enables the modelling of all tissue barriers, including the associated mechanical forces. Our technology is suitable for a wide range of applications including drug safety and efficacy testing, inhalation toxicology assessment and answering fundamental research questions. Our technology can be implemented in your laboratory, or utilised through our CRO services

Anivance AI combines organ chips with Multi-Agent AI. With 35 patents and global collaborations, we deliver plug-and-play platforms and LaaS services, supporting rare disease and inhalation models, diverse preclinical studies, and predictive, clinically-relevant data for accelerated drug discovery.

ATCC is a premier global biomaterials resource center and standards organization. We are accelerating scientific discoveries with our offerings of advanced 3D models, primary cells, iPSC-derived cells, and a wide range of other resources enabling MPS Technology.

BiomimX develops the next generation of beating organs-on-chips. uBeat® Platforms and connected hardware provide 3D miniaturized constructs with a tunable mechanical stimulation to model human organs’ function and diseases. uBeat® products and customized drug screening services are available.

Bioprinting Labs’ pillar/perfusion plates enable robust and reproducible organoid culture and in situ analysis. Our products streamline organoid-based assays by facilitating miniature organoid culture and enhancing organoid maturity through dynamic culture in the pillar/perfusion plates.

With over 25 years in nonclinical research, animal model development, and advanced cell culture systems, I offer a comprehensive perspective on the advantages and limitations of microphysiological systems in research and development programs. To learn more about Biovetality’s services, please visit: https://www.biovetality.com/

BrainXell is a CNS-focused supplier of iPSC-derived neurons, astrocytes, and microglia. Cells are made from control in-house lines and from customer-supplied disease lines. In addition, standardized and custom assays are available incorporating these cells.

We are a commercial provider of a microphysiological system either as a product or service.

CN Bio is a leading bioengineering company specializing in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines.

Curi’s suite of human iPSC-derived products and services enable scientists to build more mature and predictive human iPSC-derived tissues—with a focus on cardiac, musculoskeletal, and neuromuscular models—for the discovery, safety testing, and efficacy testing of new drugs in development.

Dynamic42 has developed a PDMS-free, easy-to-handle, affordable OoC platform. We specialize in vascular, liver, lung and intestinal biology and infection models. We further enable scientists with training courses to establish their own OoC models.

Emulate develops a breadth of Organ-Chip models with a focus on recreating the microenvironment and mechanical forces cells experience in vivo. Hardware automating media flow and stretch, Bio-Kits including chips and qualified human cells, and a range of standard and custom services are available.

Frontier Bio creates bioprinted 3D human models (BBB, lung, vasculature) to improve clinical translation and reduce reliance on animal testing.

Hesperos is accelerating drug discovery by providing safety and efficacy testing services using its Human-on-a-Chip, microphysiological system. This breakthrough technology enables unprecedented preclinical insight bringing better therapies to patients faster without the need for animal testing.

ibidi is a leading supplier of functional cell-based assays and products for cell microscopy. Its portfolio includes labware, reagents, and instruments that recreate physiological conditions for studying cell behavior, disease mechanisms, and drug effects. Customized solutions and 3D culture tools complete the offering.

ImmuONE is a product provider of immune cell models and a specialized service provider for chemical safety assessment (e.g. e-cigarettes, cosmetics, therapeutics). We offer advanced in-vitro products and offer innovative in-house testing services using state-of-the-art equipment and techniques.

As a CRO, innoVitro specializes in human-cell analytics for drug safety, toxicity, and efficacy in preclinical cardiac risk assessment.

Lena Biosciences offers Perfused Organ Panel MPS with a Blood Substitute hemoglobin analog that yields a log-fold increase in CYP450 activity in primary human hepatocytes to identify mitotoxic metabolites and DILI. Services focus on efficacy and toxicity in liver, brain, tumor, and blood models.

LifeNet Health is the world’s most trusted provider of transplant solutions — from organ recovery and technologically advanced clinical biologics and cellular therapies, to life sciences solutions that support drug discovery and medical innovation.

Luna LifeSci Advisors consults across the NAMs ecosystem, helping MPS developers grow and scale novel platforms, and guiding pharma and CROs to evaluate, adopt, and integrate MPS technologies into preclinical workflows. Our 25+ years of expertise spans strategy, technology development, platform validation, workflow integration, regulatory alignment, fundraising, company building, and commercial execution.

MEPSGEN delivers an automated MPS ecosystem designed to bridge the gap between in vitro assays and human clinical outcomes. Combining modular MEPS-X chips with the ProMEPS™ automated tissue-culture platform, MEPSGEN enables standardized, reproducible human tissue models for robust efficacy and toxicity assessment, supporting more predictive and decision-ready preclinical research.

Since 2010, Microtissues, Inc has been selling the 3D PetriDish, a reusable micro-mold platform system for forming multi-cellular spheroids and organoids from primary cells, cancer cells, stem cells and cell lines. Our products are distributed worldwide by Millipore Sigma and have been used in over 200 peer-reviewed publications, a list which is available on our website.

Mimetas develops high-throughput healthy and diseased organ-on-a-chip models in the OrganoPlate®, a screening-compatible microfluidics platform that supports the recreation of native tissue structures, and their interaction with compounds, signaling factors, disease triggers, and co-cultured cell types.

3D Cell Culture – automated, verified, standardised.

At MO:RE, we empower life science researchers to generate reproducible, quality-controlled, and human-relevant 3D cell models (NAM) that accelerate drug discovery, reduce reliance on animals, and prepare R&D pipelines for regulatory approval.

We are a Swiss high-tech company developing and offering cutting-edge biological testing solutions that enable scientists to generate insights they need to fuel life-changing discoveries in a faster, more efficient, and ethical way. Our technologies are designed to integrate seamlessly into existing lab environments, enhancing efficiency, accuracy, and reproducibility.

For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC).

NETRI is an industrial start-up developing innovative technologies for the pharmaceutical industry. Its patented organs-on-chip technologies allow the creation of standardized and predictive human in vitro models.

Optics11Life develops cutting-edge life science tools using optical fiber sensing technology. The two main products are: The Nanoindentation Platform (Pavone, Piuma and Chiaro) and The Cuore 3D Engineered Muscle Contractility Platform

I deliver expert support in NAMs specialising in dermal, respiratory, and general in vitro toxicology, MPS, and innovation across industry sectors. Services include existing and new technology evaluation, test method development, regulatory submission support, continuous improvement programs, and authoring scientific papers and expert reports. I also serve as an Expert Witness.

We are the world-leading provider of reagents and services for generating organoid and stem cell-derived models of healthy and diseased human tissues.

Organ-on-Chip models from SynVivo recreate complex microvasculature including scale, morphology, hemodynamic shear stress, and cellular interactions in a perfused microfluidic chip environment. Validated models include Air Liquid Interface for Lung, Blood-Brain Barrier, Tumor, DIVI, Inflammation.

TheWell Bioscience provides xeno-free, 3D cell culture solutions, empowering research in organoids, regenerative medicine, and drug discovery.

TissUse is a Berlin, Germany-based, biotechnology company who has developed a unique HUMIMIC Multi-Organ-Chip platform for advanced toxicity testing and cutting-edge disease modelling.

VoxCell empowers scientists and drug developers to study drug behavior with unprecedented physiological relevance. With vascular complexity at the core of our innovation, VoxCell delivers human-like models that accelerate therapeutic discovery and bridge the gap between preclinical and clinical phases. Committed to innovation and excellence, VoxCell continues to expand its impact on a global scale.

Our platform combines our unique Organ-on-a-Chip technology, multicellular 3D disease model development, and Artificial Intelligence (AI) to provide spatiotemporal profiling and analysis of drug testing and treatment at a cellular level.